KTTA, KTTAW · CIK 0001841330 · operating
Pasithea Therapeutics Corp. (KTTAW) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. The stock currently trades at $0.01, up 0.00% today, with a 52-week range of $0.01–$0.01.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.42 | $-0.42 | +0.0% | |
| 2023 | $-0.42 | $-0.42 | +20.8% | |
| 2022 | $-0.53 | $-0.55 | -152.4% | |
| 2021 | — | $-0.21 | — |